Humana (HUM)

Top Wall Street analysts changed their outlook on top names. See analyst ratings page for complete view. Check out what analysts think of HUM stock.

Humana’s second quarter results reflected operational execution and continued focus on long-term strategic goals. Management highlighted that customer growth...

AdaptHealth (NASDAQ:AHCO) reported second-quarter revenue growth in its continuing operations but lowered its full-year profitability outlook, citing higher-than-expected costs in its West Coast capitated contract, a supplier price increase and portfolio actions. Chief Executive Officer Suzanne Fos

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

What Happened? Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC) fell 14.8% in the afternoon session after the company revealed plans to ...

Humana plans more Medicare Advantage plan exits in 2027 as it targets a 3% margin and reshapes its portfolio.

UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.

Analysts change outlook on top names, including PAY, MAS, FVRR, HUM, and SITE. See their ratings and price targets on Benzinga's analyst ratings page.

Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.89 billion. Its non-G...

Humana (NYSE:HUM) said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin o

What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 7.2% in the afternoon session after the company reported a solid second-quarter earn...

HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.

GE HealthCare is among S&P 500 leaders and Humana among the laggards after both beat Q2 forecasts. Both stocks are near key levels.

Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-G...

Humana (HUM) will release Q2 earnings on July 29. Analysts expect $7 EPS and $40.57B revenue. Recent deals and ratings show potential. #HUM

Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know. Humana met analy...

Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company

UNH stock surged past a buy point, leading the Dow Jones, after Q2 earnings trounced estimates amid lower-than-expected benefit costs.